UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice

American journal of physiology. Regulatory, integrative and comparative physiology, 1997-04, Vol.272 (4), p.1204-R1209

1997

Volltextzugriff (PDF)

Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

British journal of pharmacology, 2001-09, Vol.134 (2), p.409-417

2001

Volltextzugriff (PDF)

The effect of molecular composition and crosslinking on adhesion of a bio-inspired adhesive

Polymer chemistry, 2015-01, Vol.6 (16), p.3121-3130

2015

Volltextzugriff (PDF)

Pharmacology of ezetimibe

European heart journal supplements, 2002-12, Vol.4 (suppl-J), p.J5-J8

2002

Volltextzugriff (PDF)

Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague-Dawley Rats

Obesity (Silver Spring, Md.), 2002-09, Vol.10 (9), p.956-963

2002

Volltextzugriff (PDF)

Tetrahydroisoquinolines as MCH-R1 antagonists

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (18), p.4917-4921

2006

Volltextzugriff (PDF)

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

British journal of pharmacology, 2000-04, Vol.129 (8), p.1748-1754

2000

Volltextzugriff (PDF)

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

European journal of pharmacology, 2002-04, Vol.440 (2), p.173-187

2002

Volltextzugriff (PDF)

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys

European journal of pharmacology, 2001-03, Vol.415 (1), p.79-84

2001

Volltextzugriff (PDF)

Diet-induced obese mice develop peripheral, but not central, resistance to leptin

The Journal of clinical investigation, 1997-02, Vol.99 (3), p.385-390

1997

Volltextzugriff (PDF)

In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461

The Journal of pharmacology and experimental therapeutics, 1997-10, Vol.283 (1), p.157

1997

Volltextzugriff (PDF)

Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity

Journal of medicinal chemistry, 2005-07, Vol.48 (15), p.4746-4749

2005

Volltextzugriff (PDF)

The leptin haemopoietic cytokine fold is stabilized by an intrachain disulfide bond

Hormone and metabolic research, 1996-12, Vol.28 (12), p.649-652

1996

Volltextzugriff (PDF)

Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models

European journal of pharmacology, 2010-03, Vol.630 (1), p.112-120

2010

Volltextzugriff (PDF)

Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Normalizes Combined Dyslipidemia in Obese Hyperinsulinemic Hamsters

Diabetes (New York, N.Y.), 2001-06, Vol.50 (6), p.1330-1335

2001

Volltextzugriff (PDF)

Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats

British journal of pharmacology, 2003-04, Vol.138 (8), p.1459-1464

2003

Volltextzugriff (PDF)

Purification of Milligram Quantities of Human Leptin From Recombinant E. Coli

Hormone and metabolic research, 1996-12, Vol.28 (12), p.694-697

1996

Volltextzugriff (PDF)

Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fat followed by 1 month of low-fat diet

Brain research, 2002-05, Vol.936 (1), p.87-90

2002

Volltextzugriff (PDF)

The Relationship of Tissue Localization, Distribution and Turnover to Feeding After Intraperitoneal 125I-Leptin Administration to ob/ob and db/db Mice

Hormone and metabolic research, 1996-12, Vol.28 (12), p.653-658

1996

Volltextzugriff (PDF)

Rapid normalization of pre-established hypercholesterolemia in rhesus monkeys by the potent cholesterol absorption inhibitor ezetimibe (SCH58235)

Atherosclerosis, 2000-07, Vol.151 (1), p.92-92

2000

Volltextzugriff (PDF)

Luminescence of Ag+ in crystalline and glassy SrB4O7

The Journal of physics and chemistry of solids, 1993-08, Vol.54 (8), p.901-906

1993

Volltextzugriff (PDF)

Cholesteryl Hydroperoxyoctadecadienoate from Oxidized Low Density Lipoprotein Inactivates Platelet-derived Growth Factor

The Journal of biological chemistry, 1998-07, Vol.273 (31), p.19405-19410

1998

Volltextzugriff (PDF)

The potent cholesterol absorption inhibitor, ezetimibe, ablates hypercholesterolemia and hypertriglyceridemia in a model of combined hyperlipidemia

Atherosclerosis, 2000-07, Vol.151 (1), p.132-132

2000

Volltextzugriff (PDF)

The potent cholesterol absorption inhibitor, ezetimibe, is glucuronidated in the intestine, localizes to the intestine, and circulates enterohepatically

Atherosclerosis, 2000-07, Vol.151 (1), p.155-155

2000

Volltextzugriff (PDF)

The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function

Atherosclerosis, 2000-07, Vol.151 (1), p.155-155

2000

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice

Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

The effect of molecular composition and crosslinking on adhesion of a bio-inspired adhesive

Pharmacology of ezetimibe

Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague-Dawley Rats

Tetrahydroisoquinolines as MCH-R1 antagonists

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys

Diet-induced obese mice develop peripheral, but not central, resistance to leptin

In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461

Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity

The leptin haemopoietic cytokine fold is stabilized by an intrachain disulfide bond

Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models

Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Normalizes Combined Dyslipidemia in Obese Hyperinsulinemic Hamsters

Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats

Purification of Milligram Quantities of Human Leptin From Recombinant E. Coli

Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fat followed by 1 month of low-fat diet

The Relationship of Tissue Localization, Distribution and Turnover to Feeding After Intraperitoneal 125I-Leptin Administration to ob/ob and db/db Mice

Rapid normalization of pre-established hypercholesterolemia in rhesus monkeys by the potent cholesterol absorption inhibitor ezetimibe (SCH58235)

Luminescence of Ag+ in crystalline and glassy SrB4O7

Cholesteryl Hydroperoxyoctadecadienoate from Oxidized Low Density Lipoprotein Inactivates Platelet-derived Growth Factor

The potent cholesterol absorption inhibitor, ezetimibe, ablates hypercholesterolemia and hypertriglyceridemia in a model of combined hyperlipidemia

The potent cholesterol absorption inhibitor, ezetimibe, is glucuronidated in the intestine, localizes to the intestine, and circulates enterohepatically

The novel cholesterol absorption inhibitor, ezetimibe, selectively inhibits the intestinal absorption of free cholesterol in the presence and absence of exocrine pancreatic function

Suchergebnisse filtern